SCHEMBL5831487

SCHEMBL5831487

CCCCCCCCCCC(CO)OC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.54
MAPT P10636 2/20 0.47
MAPK1 P28482 1/20 0.47
CYP2D6 P10635 2/20 0.45
SPHK1 Q9NYA1 1/20 0.45
GMNN O75496 1/20 0.45
POLB P06746 1/20 0.45
THPO P40225 1/20 0.45
MTOR P42345 1/20 0.45
BLM P54132 1/20 0.45
KDM4E B2RXH2 1/20 0.45
TP53 P04637 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CETP P11597 1/20 0.45
HTT P42858 1/20 0.45
UBE2N P61088 1/20 0.45
USP2 O75604 1/20 0.44
ZDHHC7 Q9NXF8 1/20 0.42
LPAR6 P43657 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7612390 1.00 LMNA (0.54) LMNAMAPTMAPK1CYP2D6SPHK1
SCHEMBL10529810 1.00 LMNA (0.54) LMNAMAPTMAPK1CYP2D6SPHK1
SCHEMBL4414640 1.00 LMNA (0.54) LMNAMAPTMAPK1CYP2D6SPHK1
SCHEMBL24219844 1.00 LMNA (0.54) LMNAMAPTMAPK1CYP2D6SPHK1
SCHEMBL3991828 1.00 LMNA (0.54) LMNAMAPTMAPK1CYP2D6SPHK1
SCHEMBL23630665 1.00 LMNA (0.54) LMNAMAPTMAPK1CYP2D6SPHK1
SCHEMBL7030936 1.00 LMNA (0.54) LMNAMAPTMAPK1CYP2D6SPHK1
SCHEMBL7747262 1.00 LMNA (0.54) LMNAMAPTMAPK1CYP2D6SPHK1
SCHEMBL10935489 1.00 LMNA (0.54) LMNAMAPTMAPK1CYP2D6SPHK1
SCHEMBL11727258 1.00 LMNA (0.54) LMNAMAPTMAPK1CYP2D6SPHK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230338250-A1 Compositions Comprising One or More (Bio)-Alkanediols with Active Ingredients SYMRISE AG (DE) 2023-10-26 US disclosed
US-7132092-B2 Metallized mesoporous silicate and method of oxidation with the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-11-07 US disclosed
US-20050090688-A1 Metallized mesoporous silicate and method of oxidation with the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2005-04-28 US disclosed
EP-1473275-A1 METALLIZED MESOPOROUS SILICATE AND METHOD OF OXIDATION WITH THE SAME Sumitomo Chemical Company, Limited (JP) 2004-11-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230338250-A1 Compositions Comprising One or More (Bio)-Alkanediols with Active Ingredients DERL1, DHCR7, DHCR24 LMNA 2048/4885MAPT 1166/4885MAPK1 2299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.